XML 24 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (28,753,844) $ (8,882,938)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 363,085 2,780
Amortization of debt discounts issuance and warrants 1,425,679
Shares issued for services 25,000
Shares issued for interest expense 8,523
Change in value of warrant liabilities (1,424,603)
Commitment shares issued for equity line of credit 568,235
Common shares issuance for services 595,841
Stock-based compensation 4,265,957 268,300
Amortization of non-cash prepaids 1,037,631
Accounts payable 8,274,316 (1,053,331)
Accrued expenses 893,992 358,510
Accrued interest on convertible notes 613,605
Accrued Payroll and payroll taxes (59,186) (48,423)
Net cash used in operating activities (14,238,576) (7,282,295)
CASH FLOWS FROM INVESTING ACTIVITIES    
Patent License Acquisition (466,423)
Net cash used in investing activities (466,423)
CASH FLOWS FROM FINANCING ACTIVITIES    
Prepaid warrants (net of fees) 530,162
Common stock issuance (net of fees) 7,858,140
Short-term borrowings 250,000
Short-term loan repayments (250,000)
Sale of preferred stock 1,053,000 6,050,000
Initial public offering (net of fees) 5,225,840
Net proceeds from conversion of debt A, B, C, D, E & F 1,501,000
Net cash provided by financing activities 9,441,302 12,776,840
Net change in cash (5,263,697) 5,495,545
Cash – beginning of period 5,533,527 38,982
Cash – end of period 269,830 5,533,527
Cash paid for interest
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Discount on notes payable – redemption premium 750,500
Dividends payable 31,250
Deemed dividend on Series A convertible preferred stock 1,971,975
Mezzanine equity conversion (net of costs) 3,730,121
Conversion of preferred stock to common stock 1,302
Amortization of deferred offering costs 751,050
Conversion of convertible notes into common stock 24,757,252
Conversion of warrants into common stock 411
Issuance of common stock to investor advisor – settlement 320
Conversion of make-whole liability to common stock 130,000
Clawback of common stock for over issuance (670)
Common stock issued for patent purchase 6,398,015
Reclassification of warrants liability to equity 878,153
Shares issued for prepaid services $ 1,100,713